Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients with Anaplastic Thyroid Cancer.

Lori J. Wirth,Marcia S. Brose,Eric J. Sherman,Lisa Licitra,Martin Schlumberger,Steven Sherman,Keith C. Bible,Bruce Robinson,Patrice Rodien,Yann Godbert,Christelle De La Fouchardiere,Kate Newbold,Christopher Nutting,Soamnauth Misir,Ran Xie,Ana Almonte,Weifei Ye,Maria E. Cabanillas

Journal of clinical oncology（2021）

引用 47|浏览37

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要